News
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome.
Friday 27 February 2026
